Erratum (DOI:10.1016/j.joms.2008.02.004);Clinical Concerns of Alendronate Use

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 6, 2008, Pages 1322-

  Marx, Robert E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; RISEDRONIC ACID;

BONE NECROSIS; DRUG EFFECT; FOOD AND DRUG ADMINISTRATION; HUMAN; JAW DISEASE; LETTER; PRESCRIPTION; PROTHROMBIN TIME; RISK FACTOR;

EID: 43449138473     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.06.019     Document Type: Erratum

References (2)

1. J.L. Rutkowsi D.A. Johnson D.M. Smith Clinical concerns of alendronate use J Oral Maxillofac Surg 65 2007 363
2. M. Etiminan K. Aminzadek E.R. Matthew Use of oral bisphosphonates and the risk of aseptic osteonecrosis: A nested case control study J Rheumatol 35 2008 3